Direct Oral Anticoagulants vs. Vitamin-K Antagonists in the Elderly With Atrial Fibrillation: A Systematic Review Comparing Benefits and Harms Between Observational Studies and Randomized Controlled Trials-Reference-Cited by-同舟云学术

Direct Oral Anticoagulants vs. Vitamin-K Antagonists in the Elderly With Atrial Fibrillation: A Systematic Review Comparing Benefits and Harms Between Observational Studies and Randomized Controlled Trials

Published:2020-09-10 Issue: Volume:7 Page:
ISSN:2297-055X
Container-title:Frontiers in Cardiovascular Medicine
language:
Short-container-title:Front. Cardiovasc. Med.

Author:

Shen Nan-Nan,Wu Yue,Wang Na,Kong Ling-Cong,Zhang Chi,Wang Jia-Liang,Gu Zhi-Chun,Chen Jin

Publisher

Frontiers Media SA

Subject

Cardiology and Cardiovascular Medicine

Reference42 articles.

1. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study;Lloyd-Jones;Circulation,2004

2. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe;Lip;Chest,2012

3. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation;Lip;Chest,2010

4. Epidemiology of atrial fibrillation: European perspective;Zoni-Berisso;Clin Epidemiol,2014

5. Stroke prevention in atrial fibrillation;Freedman;Lancet,2016

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Decade of Experience;Drugs & Aging;2024-08-14

2. Oral anticoagulant therapy in older adults;Thrombosis Research;2024-06

3. Oral Anticoagulants Beyond Warfarin;Annual Review of Pharmacology and Toxicology;2024-01-23

4. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study;Cochrane Database of Systematic Reviews;2024-01-04

5. Meta-análisis: Eficacia y seguridad de apixabán frente a warfarina en pacientes con fibrilación auricular para profilaxis de eventos cardiovasculares adversos;CEDAMAZ;2022-12-29